Marshall Wace’s Annexon ANNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
210,607
-650,868
-76% -$3.6M ﹤0.01% 2105
2026
Q1
$4.77M Buy
861,475
+340,477
+65% +$1.92M ﹤0.01% 1330
2025
Q4
$2.62M Buy
+520,998
New +$1.99M ﹤0.01% 1445
2025
Q3
Sell
-29,989
Closed -$72K 2863
2025
Q2
$72K Buy
+29,989
New +$60.1K ﹤0.01% 2570
2025
Q1
Sell
-38,845
Closed -$199K 2606
2024
Q4
$199K Sell
38,845
-253,529
-87% -$1.56M ﹤0.01% 2353
2024
Q3
$1.73M Sell
292,374
-1,401,291
-83% -$8.31M ﹤0.01% 1423
2024
Q2
$8.3M Buy
1,693,665
+1,378,053
+437% +$7.13M 0.01% 817
2024
Q1
$2.26M Buy
+315,612
New +$1.64M ﹤0.01% 1305
2023
Q2
Sell
-464,819
Closed -$1.79M 2435
2023
Q1
$1.79M Buy
464,819
+435,963
+1,511% +$2.4M ﹤0.01% 1512
2022
Q4
$149K Buy
+28,856
New +$159K ﹤0.01% 2738
2022
Q3
Sell
-14,961
Closed -$56K 3305
2022
Q2
$56K Sell
14,961
-13,211
-47% -$40.4K ﹤0.01% 3324
2022
Q1
$77K Buy
28,172
+21,912
+350% +$135K ﹤0.01% 3219
2021
Q4
$73K Buy
+6,260
New +$101K ﹤0.01% 3465

Other funds holding ANNX

Marshall Wace's ANNX Position: Q2 2026 in Review

Marshall Wace reduced its Annexon (ANNX) stake by 76% in Q2 2026, selling an estimated $3.6M and leaving 210,607 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

Marshall Wace first reported a position in ANNX in Q4 2021 and has held it in 13 quarters since. The position peaked at $8.3M in Q2 2024. 216 funds tracked by Wall St. Rank hold ANNX as of Q2 2026.

  • Marshall Wace held 210,607 shares of Annexon worth $1.2M as of Q2 2026.
  • Marshall Wace sold 650,868 Annexon shares in Q2 2026, an estimated $3.6M.
  • Annexon made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2105 holding.
  • Marshall Wace first reported a position in Annexon in Q4 2021 and has held it in 13 quarters since.
  • Marshall Wace's Annexon position peaked at $8.3M in Q2 2024.
  • 216 funds tracked by Wall St. Rank held Annexon as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.